Back to School: How biopharma can reboot drug development. Access exclusive analysis here

FDA panel backs new warnings for influenza drugs

An FDA advisory committee Tuesday voted 8-6 to recommend revising the label of Tamiflu oseltamivir from Roche (SWX:ROG) to replace language that suggests the drug

Read the full 255 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE